These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2938613

  • 1. Does 2-mercaptoethane sulphonate (mesna) prevent cyclophosphamide and azathioprine induced immunosuppression? In vitro studies.
    Al-Safi SA, Maddocks JL.
    Br J Clin Pharmacol; 1986 Mar; 21(3):267-70. PubMed ID: 2938613
    [Abstract] [Full Text] [Related]

  • 2. [Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
    Brock N, Stekar J.
    Arzneimittelforschung; 1982 Mar; 32(5):486-7. PubMed ID: 6809014
    [Abstract] [Full Text] [Related]

  • 3. Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity.
    Sangster G, Kaye SB, Calman KC, Dalton JF.
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):435-6. PubMed ID: 6423391
    [No Abstract] [Full Text] [Related]

  • 4. The prevention of cyclophosphamide-induced bladder swelling in the rat by I.V. administration of sodium-2-mercaptoethane sulfonate.
    Kedar A, Simpson CL, Williams P, Moore R, Tritsch G, Murphy GP.
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):339-48. PubMed ID: 6774389
    [Abstract] [Full Text] [Related]

  • 5. [Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].
    Schmähl D, Habs M, Tacchi AM.
    Urologe A; 1984 Sep; 23(5):291-6. PubMed ID: 6438859
    [Abstract] [Full Text] [Related]

  • 6. N-acetylcysteine and 2-mercaptoethane sulphonate inhibit anti-pseudomonas activity of antibiotics in vitro.
    Alfredsson H, Malmborg AS, Strandvik B.
    Eur J Respir Dis; 1987 Apr; 70(4):213-7. PubMed ID: 3108021
    [Abstract] [Full Text] [Related]

  • 7. Treatment of ifosfamide-induced urothelial toxicity by oral administration of sodium 2-mercaptoethane sulphonate (MESNA) to patients with inoperable lung cancer.
    Araujo CE, Tessler J.
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):195-201. PubMed ID: 6402369
    [Abstract] [Full Text] [Related]

  • 8. Interaction of Mesna (2-mercaptoethane sulfonate) with the mutagenicity of cyclophosphamide in vitro and in vivo.
    Lähdetie J, Räty R, Sorsa M.
    Mutat Res; 1990 Sep; 245(1):27-32. PubMed ID: 2118231
    [Abstract] [Full Text] [Related]

  • 9. Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma.
    Bryant BM, Jarman M, Ford HT, Smith IE.
    Lancet; 1980 Sep 27; 2(8196):657-9. PubMed ID: 6106781
    [Abstract] [Full Text] [Related]

  • 10. Comparison of reduced glutathione with 2-mercaptoethane sulfonate to prevent cyclophosphamide-induced urotoxicity.
    Cavalletti E, Tofanetti O, Zunino F.
    Cancer Lett; 1986 Jul 27; 32(1):1-6. PubMed ID: 3091245
    [Abstract] [Full Text] [Related]

  • 11. The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis.
    Ehrlich RM, Freedman A, Goldsobel AB, Stiehm ER.
    J Urol; 1984 May 27; 131(5):960-2. PubMed ID: 6423841
    [Abstract] [Full Text] [Related]

  • 12. Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna).
    Habs MR, Schmähl D.
    Cancer; 1983 Feb 15; 51(4):606-9. PubMed ID: 6401591
    [Abstract] [Full Text] [Related]

  • 13. Arginine 2-mercaptoethane sulfonate and sodium 2-mercaptoethane sulfonate: a comparative study of their effects upon tumour cells.
    Magnolfi Zipoli G, D'Ancona S, Berti T.
    Drugs Exp Clin Res; 1988 Feb 15; 14(7):473-8. PubMed ID: 3149236
    [Abstract] [Full Text] [Related]

  • 14. Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study.
    Freedman A, Ehrlich RM, Ljung BM.
    J Urol; 1984 Sep 15; 132(3):580-2. PubMed ID: 6433044
    [Abstract] [Full Text] [Related]

  • 15. In vitro/in vivo effects of Mesna on the genotoxicity and toxicity of cyclophosphamide--a study aimed at clarifying the mechanism of Mesna's anticarcinogenic activity.
    Pool BL, Bos RP, Niemeyer U, Theuws JL, Schmähl D.
    Toxicol Lett; 1988 Apr 15; 41(1):49-56. PubMed ID: 3128896
    [Abstract] [Full Text] [Related]

  • 16. Sodium 2-mercaptoethane sulfonate protection against cyclophosphamide-induced teratogenicity in rats.
    Slott VL, Hales BF.
    Toxicol Appl Pharmacol; 1986 Jan 15; 82(1):80-6. PubMed ID: 3080822
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects.
    James CA, Mant TG, Rogers HJ.
    Br J Clin Pharmacol; 1987 May 15; 23(5):561-8. PubMed ID: 3109461
    [Abstract] [Full Text] [Related]

  • 18. Effect of thiol derivatives on mixed mucus and blood clots in vitro.
    Risack LE, Vandevelde ME, Gobert JG.
    Resuscitation; 1978 May 15; 6(1):9-20. PubMed ID: 97741
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.